On February 10, 2022 CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, reported that management will participate in two virtual investor conferences including the 11th Annual SVB Leerink Global Healthcare Conference taking place February 14-18, 2022 and Oppenheimer’s 32nd Annual Healthcare Conference taking place March 15-16, 2022 (Press release, CymaBay Therapeutics, FEB 10, 2022, View Source [SID1234607959]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

11th Annual SVB Leerink Global Healthcare Conference
Date: Thursday, February 17
Time: 3:00pm Eastern Time Fireside Chat
Webcast: View Source

Oppenheimer’s 32nd Annual Healthcare Conference
Date: Wednesday, March 16
Time: 4:40pm Eastern Time Fireside Chat
Webcast: View Source